1. Home
  2. IPHA vs FC Comparison

IPHA vs FC Comparison

Compare IPHA & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.43

Market Cap

167.6M

Sector

Health Care

ML Signal

N/A

Logo Franklin Covey Company

FC

Franklin Covey Company

N/A

Current Price

$16.04

Market Cap

195.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
IPHA
FC
Founded
1999
1983
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
195.7M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
IPHA
FC
Price
$1.43
$16.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.67
★ $31.00
AVG Volume (30 Days)
17.5K
★ 40.8K
Earning Date
09-17-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $267,067,000.00
Revenue This Year
$390.56
$5.10
Revenue Next Year
$143.06
$6.15
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.17
$11.16
52 Week High
$2.71
$26.81

Technical Indicators

Market Signals
Indicator
IPHA
FC
Relative Strength Index (RSI) 42.83 31.52
Support Level $1.38 $11.16
Resistance Level $1.59 $19.17
Average True Range (ATR) 0.07 0.84
MACD 0.01 -0.22
Stochastic Oscillator 39.29 10.72

Price Performance

Historical Comparison
IPHA
FC

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.

Share on Social Networks: